AbbVie has rewarded shareholders again with a quarterly dividend. As a Dividend King, it is the epitome of a steady and ...

State of New Jersey Common Pension Fund D decreased its stake in Veracyte, Inc. (NASDAQ:VCYT – Free Report) by 31.4% in the ...

Kennedy is Trump’s pick for health secretary, but he has a history of spreading misinformation about a range of issues.

Blueprint Medicines' AYVAKIT leads its revenue growth, while its pipeline targets multiple cancers. Read why BPMC stock is a ...

His nomination to head the HHS by President-elect Donald Trump on Thursday could bring sweeping changes to the way Washington, D.C., targets health issues.

As previously reported, Wolfe Research initiated coverage of Veracyte (VCYT) with an Outperform rating and $50 price target The genomic ...

Analyst Vikram Purohit of Morgan Stanley maintained a Hold rating on ACELYRIN, INC. (SLRN – Research Report), retaining the price target ...

President-elect Donald Trump is expected to nominate Robert F. Kennedy Jr. ― an anti-vaccine conspiracy theorist who formerly ...

The findings could reassure policymakers concerned that virtual care could increase unnecessary or wasteful services.

Analysts have set 12-month price targets for Amgen, revealing an average target of $349.0, a high estimate of $405.00, and a ...

Assetmark Inc. boosted its stake in shares of Genmab A/S (NASDAQ:GMAB – Free Report) by 16.2% during the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 82,629 shares of ...